- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05920954
Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis
Acute Cholangitis is an emergency associated with significant morbidity and mortality which require prompt recognition and treatment. The decompression of biliary tree along with antibiotics are mainstay of therapy. Randomized comparative studies showed that ERCP achieves biliary decompression with markedly less morbidity and mortality compared with surgery, regardless of clinical drainage. Percutaneous trans hepatic drainage (PTBD) can be alternative to endoscopic drainage in selected group especially advanced hilar strictures and patients who are unfit for endoscopic procedure.
Recent ASGE guidelines suggested the performance of ERCP within 48 hours for patients with acute cholangitis; however it is conditional recommendation with very low quality of evidence. Till date, no randomized trial has compared urgent ERCP versus early ERCP for acute cholangitis.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hardik Rughwani, MD, DM
- Phone Number: +91 9426928600
- Email: hardik.hr@gmail.com
Study Locations
-
-
Telangana
-
Hyderabad, Telangana, India, 500032
- Recruiting
- AIG Hospitals
-
Contact:
- Hardik RAMESH RUGHWANI, DM
- Phone Number: 9426928600
- Email: hardik.hr@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients who met criteria for a definite diagnosis acute cholangitis.
Exclusion Criteria:
- Patients with severe acute cholangitis at admission.
- Age < 18 years.
- Pregnancy.
- Associated Acute Severe Pancreatitis.
- Patients with suspected high grade (Bismuth III/IV) biliary stricture in whom PTBD is considered as primary method of biliary drainage.
- Not giving consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Urgent ERCP
Urgent ERCP (<24 Hours).
|
Repeat ERCP
|
Experimental: Early ERCP
Early ERCP(24 to 48 Hours).
|
Repeat ERCP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization
Time Frame: Two Years
|
To perform a single-centre, randomized trial comparing the efficacy (the ability to produce a desired or intended result) of urgent versus early ERCP (Endoscopic retrograde cholangiopancreatography) for reducing the risk of 30 days of mortality.
|
Two Years
|
ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization
Time Frame: Two Years
|
PRIMARY OUTCOME: 30 day mortality
|
Two Years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ERCP performed within 24 hours of hospitalization versus ERCP performed between 24 to 48 hours of hospitalization
Time Frame: Two Years
|
|
Two Years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Urgent ERCP vs Early ERCP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Cholangitis
-
Ohio State UniversityStryker InstrumentsCompletedAcute Cholecystitis | Acute CholangitisUnited States
-
Nantes University HospitalUnknown
-
Seoul National University HospitalActive, not recruitingAcute CholangitisKorea, Republic of
-
Ziv HospitalUnknownAcute Cholecystitis | Biliary Colic | Acute CholangitisIsrael
-
Beijing Friendship HospitalRecruitingCholedocholithiasis With Acute CholangitisChina
-
Peking University Third HospitalNot yet recruitingCommon Bile Duct Calculi | Acute Cholangitis | Acute; Cholecystitis, Choledocholithiasis | Acute Cholecystitis With ObstructionChina
-
Beijing Friendship HospitalRecruitingCholedocholithiasis With Acute CholangitisChina
-
Medical University of WarsawNational Science Centre, PolandRecruitingPrimary Sclerosing Cholangitis (PSC)Poland
-
Mayo ClinicActive, not recruiting
-
Cascade Pharmaceuticals, IncCovanceCompletedPrimary Sclerosing Cholangitis (PSC)United States
Clinical Trials on ERCP
-
First People's Hospital of HangzhouCompletedCholedocholithiasis | Common Bile Duct CalculiChina
-
McGill University Health Centre/Research Institute...Unity Health Toronto; Jewish General HospitalRecruitingCancer GiCanada, France, India
-
Minia UniversityCompletedGallstones Complicated by CBD StonesEgypt
-
Weill Medical College of Cornell UniversityUnknownPancreatic Cancer | Cholangiocarcinoma | Bile Duct Cancer | Chronic Pancreatitis | Biliary Stricture | Biliary Obstruction | Ampullary Cancer | Stent Obstruction | Proximal Duct Stricture | Distal Duct Stricture | Biliary Sphincter Stenosis | Impacted Stones | Peri-ampullary Diverticula | Altered AnatomyUnited States, Brazil
-
Beijing Friendship HospitalRecruitingCholedocholithiasis With Acute CholangitisChina
-
Beijing Friendship HospitalRecruitingCholedocholithiasis With Acute CholangitisChina
-
Mansoura UniversityCompleted
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedSphincter of Oddi DysfunctionUnited States
-
University of FloridaCompletedBile Duct Stricture | Accuracy of Tissue Diagnosis | Pancreatic Duct StrictureUnited States
-
Yonsei UniversityNot yet recruitingResectable Pancreatic Cancer With Biliary ObstructionKorea, Republic of